Evidence map›Paper›PMID 26705736›Full record

ArticleNeuroscience2016

Altered vesicular glutamate transporter distributions in the mouse cochlear nucleus following cochlear insult.

A N Heeringa, R A Stefanescu, Y Raphael, S E Shore

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Effects ofNutrients · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Comparison of Responses to DCN vs. VCN Stimulation in a Mouse Model of the Auditory Brainstem Implant (ABI).Journal of the Association for Research in Otolaryngology : JARO · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Gαi Proteins are Indispensable for Hearing.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2018
    Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

A N HeeringaKresge Hearing Research Institute, Otolaryngology, University of Michigan, United States.
R A StefanescuKresge Hearing Research Institute, Otolaryngology, University of Michigan, United States.
Y RaphaelKresge Hearing Research Institute, Otolaryngology, University of Michigan, United States.
S E ShoreKresge Hearing Research Institute, Otolaryngology, University of Michigan, United States; Molecular and Integrative Physiology, University of Michigan, United States; Biomedical Engineering, University of Michigan, United States. Electronic address: sushore@umich.edu.
Kresge Eye Institute · USMichigan United · US

Funding

Scientific Synergy CoreP30DC005188 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DOLAN, DAVID FRANCIS · 2002 to 2016
$10.3M
Sensory Mechanisms and Disorders - Administrative SupplementT32DC000011 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Michael Thomas Roberts · 1989 to 2026
$9.5M
Function of trigeminal pathways to the cochlear nucleusR01DC004825 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHORE, SUSAN E · 2001 to 2016
$5.5M
NIDCD NIH HHS P30 DC005188NIDCD NIH HHS P30 DC-05188NIDCD NIH HHS R01 DC004825NIDCD NIH HHS T32 DC000011
6 · The paper itself

Abstract

Vesicular glutamate transporters 1 and 2 (VGLUT1 and VGLUT2) have distinct distributions in the cochlear nucleus that correspond to sources of the labeled terminals. VGLUT1 is mainly associated with terminals of auditory nerve fibers, whereas VGLUT2 is mainly associated with glutamatergic terminals deriving from other sources that project to the cochlear nucleus (CN), including somatosensory and vestibular terminals. Previous studies in guinea pig have shown that cochlear damage results in a decrease of VGLUT1-labeled puncta and an increase in VGLUT2-labeled puncta. This indicates cross-modal compensation that is of potential importance in somatic tinnitus. To examine whether this effect is consistent across species and to provide a background for future studies, using transgenesis, the current study examines VGLUT expression profiles upon cochlear insult by intracochlear kanamycin injections in the mouse. Intracochlear kanamycin injections abolished ipsilateral ABR responses in all animals and reduced ipsilateral spiral ganglion neuron densities in animals that were sacrificed after four weeks, but not in animals that were sacrificed after three weeks. In all unilaterally deafened animals, VGLUT1 density was decreased in CN regions that receive auditory nerve fiber terminals, i.e., in the deep layer of the dorsal cochlear nucleus (DCN), in the interstitial region where the auditory nerve enters the CN, and in the magnocellular region of the antero- and posteroventral CN. In contrast, density of VGLUT2 expression was upregulated in the fusiform cell layer of the DCN and in the granule cell lamina, which are known to receive somatosensory and vestibular terminals. These results show that a cochlear insult induces cross-modal compensation in the cochlear nucleus of the mouse, confirming previous findings in guinea pig, and that these changes are not dependent on the occurrence of spiral ganglion neuron degeneration.

Indexed as

AnimalsCell CountCochlear DiseasesCochlear NucleusDeafnessDisease Models, AnimalEvoked Potentials, Auditory, Brain StemFunctional LateralityImmunohistochemistryKanamycinMice, Inbred C57BLNeuronsSpiral GanglionVesicular Glutamate Transport Protein 1Vesicular Glutamate Transport Protein 2KanamycinSlc17a6 protein, mouseSlc17a7 protein, mouseVesicular Glutamate Transport Protein 1Vesicular Glutamate Transport Protein 2cochlear damagecochlear nucleusmultisensoryplasticitytinnitusvesicular glutamate transporters

Identifiers

PMID26705736
PMCPMC4715966
OpenAlexW2212530199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.